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Abstract
Background Stent placement in the distal duodenum or
proximal jejunum with a therapeutic gastroscope can be
difficult, because of the reach of the endoscope, loop for-
mation in the stomach, and flexibility of the gastroscope.
The use of a colonoscope may overcome these problems.
Objective To report our experience with distal duodenal
stent placement in 16 patients using a colonoscope.
Methods Multicenter, retrospective series of patients with
a malignant obstruction at the level of the distal duodenum
and proximal jejunum and treated by stent placement using
a colonoscope. Main outcome measurements are technical
success, ability to eat, complications, and survival.
Results Stent placement was technically feasible in 93%
(15/16) of patients. Food intake improved from a median
gastric outlet obstruction scoring system (GOOSS) score of 1
(no oral intake) to 3 (soft solids) (p = 0.001). Severe com-
plications were not observed. One patient had persistent
obstructive symptoms presumably due to motility problems.
Recurrent obstructive symptoms were caused by tissue/
tumor ingrowth through the stent mesh [n = 6 (38%)] and
stent occlusion by debris [n = 1 (6%)]. Reinterventions
included additional stent placement [n = 5 (31%)], gastro-
jejunostomy [n = 2 (12%)], and endoscopic stent cleansing
[n = 1 (6%)]. Median survival was 153 days.
Conclusion Duodenal stent placement can effectively and
safely be performed using a colonoscope in patients with
an obstruction at the level of the distal duodenum or
proximal jejunum. A colonoscope has the advantage that it
is long enough and offers good endoscopic stiffness, which
avoids looping in the stomach.
Keywords GI \ cancer  G-I \ endoscopy, technical \
endoscopy  Therapeutic/palliation \ endoscopy
Patients with gastrointestinal malignancies may develop an
obstruction at the level of the duodenum. The largest group
consists of patients with pancreatic cancer, who develop in
10–20% of cases a gastric outlet obstruction (GOO) [1–3].
Other causes of GOO include periampullary carcinoma,
lymphoma, primary duodenal carcinoma as well as
metastases to the duodenum [4–6]. Palliative treatment of
GOO is mandatory as it is associated with a rapid deteri-
oration of the clinical status due to vomiting, dehydration,
and malnutrition [2].
Stent placement is a commonly used palliative treatment,
because this modality is less invasive compared with a sur-
gically performed gastrojejunostomy. In addition, results of
small randomized trials concluded that stent placement was
superior to gastrojejunostomy [7, 8]. Stent placement in
patients with a malignant obstruction at the level of the distal
stomach or proximal duodenum (superior, descending and
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first half of the horizontal part) is routinely performed with a
therapeutic gastroscope. However, stent placement in the
distal part of the duodenum (second half of the horizontal
part and ascending part of the duodenum) or proximal jeju-
num with a therapeutic gastroscope can be difficult. The
main factors limiting the use of a gastroscope for distal
duodenal stenting are the relatively short endoscope length,
and shaft flexibility, which may cause looping of the scope
into the stomach. The use of a colonoscope may potentially
overcome these problems [6, 9–11].
In this series, we report our experience with distal duo-
denal stent placement in 16 patients using a colonoscope.
Patients and methods
Patients
All patients with a malignant obstruction at the level of the
distal duodenum and proximal jejunum and treated by stent
placement using a colonoscope at the Erasmus MC-Uni-
versity Medical Center Rotterdam, The Netherlands, the
University Medical Center Utrecht, The Netherlands and
Istituto Clinico Humanitas, Milan, Italy in the period 2001–
2006 were included. Data were obtained from the clinical
records and endoscopy report databases at both centers, and
by telephone interviews with patients and/or their treating
physicians or general practitioners. Information that was
collected included demographic information, procedural
characteristics, and follow-up information on complica-
tions, persistent and recurrent obstructive symptoms,
reinterventions, and survival.
Endoscopic procedure
All stents were placed using a colonoscope after an intra-
venous dose of midazolam (Roche, Basel, Switzerland) or
propofol (AstraZeneca, Zoetermeer, The Netherlands). The
length of the stricture was determined using contrast fluo-
roscopy of the duodenum during the procedure. A guide
wire was then introduced through the stricture and the stent
was advanced over the wire. Stent length was chosen to
aim at a length of 1–2 cm more than the stricture. Endos-
copy and fluoroscopy were used to follow stent
deployment. Immediately after the procedure, an upright
abdominal X-ray was performed to assess that no perfo-
ration had occurred during the procedure.
Follow-up information
Food intake was measured by the standardized gastric
outlet obstruction scoring system (GOOSS score), with
1 = no oral intake, 2 = liquids only, 3 = soft solids, and
4 = full diet [2]. The GOOSS score was measured before
and 1 week after stent placement. Based on this score,
clinical success was defined as relief of symptoms and
improvement of oral intake until at least soft solids
(GOOSS = 3) 1 week after the procedure. Technical suc-
cess of stent placement was defined as adequate positioning
and deployment of the stent with complete bridging of the
stenosis.
Complications included life-threatening or severe com-
plications, for example, perforation and stent migration.
Persistent obstructive symptoms were defined as contin-
uing obstructive symptoms occurring within 2 weeks after
the intervention, whereas recurrent obstructive symptoms
were defined as symptoms occurring more than 2 weeks
after treatment. A reintervention was defined as a treatment
for a complication, or persistent or recurrent obstructive
symptoms.
Statistics
The GOOSS score before and 1 week after stent placement
was compared with the Wilcoxon rank sum test. Survival
was calculated by Kaplan–Meier analysis. Calculations were
performed with SPSS 12.0. A two-sided p-value \ 0.05 was
considered statistically significant.
Results
Patient characteristics
In the period 2001–2006, enteral Wallstents (Boston Sci-
entific, Natick, MA) (n = 12) or Wallflex stents (Boston
Scientific) (n = 4) were placed using a colonoscope in
16 patients (11 men, 5 women). Table 1 shows the baseline
characteristics of these patients (mean age: 70.1 ±
9.4 years). Obstruction was caused by pancreatic cancer
(n = 8), duodenal cancer (n = 2), colorectal cancer
(n = 2), lymphoma (n = 1), and metastases from renal cell
(n = 1), lung (n = 1), and liver cancer (n = 1). Sites of
obstruction were the second half of the horizontal and
ascending part of the duodenum (n = 10), duodenojejunal
flexure (n = 5), and proximal jejunum (n = 1). Main study
outcomes are shown in Table 2.
Technical success
In nine patients, initial stent placement using a gastroscope
was unsuccessful. In all these patients a GIF-1T145 gas-
troscope (Olympus America Inc., Center Valley, PA, USA)
had been used. Therefore, this endoscope was changed for
a colonoscope (CF0165 or CF0180 colonoscope (Olympus
Japan Inc.). In the following seven patients, we primarily
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used a colonoscope (CF0165 or CF0180 colonoscope
(Olympus Japan Inc.). Stent placement with a colonoscope
was technically feasible in 93% (15/16) of patients (Fig. 1;
video). In one patient, persistent obstructive symptoms
were present after the procedure. It was found that the
primary stent had not completely bridged the tumor. In this
patient, a second stent was placed 1 day later.
Food intake
Food intake improved in all patients [improvement of median
GOOSS score from 1 (before stent placement) to 3 (1 week
after) (p = 0.001)]. One patient was only able to drink liquids
1 week after stent placement (GOOSS score: 2). Clinical
success was therefore considered to be 94% (15/16).
Complications
Severe complications were not observed during the follow-up
period. Recurrent obstructive symptoms occurred in seven
patients after a median of 240 days (range 13 to 270 days)
due to tissue/tumor ingrowth (n = 7) and stent occlusion
by debris (n = 1). One patient suffered tumor ingrowth
twice, 92 days and 242 days after initial stent placement.
Table 1 Characteristics of 16 patients treated with distal duodenum stent placement using a colonoscope
Pat Age Gender Obstruction
site
Technical
success
GOOSS score Complications Recurrent
obstruction
Persistence Reintervention Survival
(days)
Before After
1 67 F Horizontal part Yes 1 3 No Tissue/Tumor
ingrowth at day
92 + 242
No Stent placement
(92)
365
2 55 F Ascending part Yes 1 4 No No No No 184
3 87 M Horizontal part Yes 2 3 No No No No 184
4 73 M Horizontal part Yes 3 4 No No No No 120
5 69 M Horizontal part Yes 2 4 No No No No 153
6 71 M Ascending part Yes 2 4 No Tissue/tumor
ingrowth at
day 63
No Stent
placement
168
7 76 F Horizontal part Yes 2 3 No Tissue/tumor
ingrowth at
day 241
No Gastrojejunostomy 243
8 81 M Ascending part Yes 2 3 No Tissue/tumor
ingrowth at
day 273
No Stent
placement
302
9 78 M Proximal
jejunum
Yes 2 4 No Debris in stent
at day 21
No Endoscopy 273
10 81 M Ascending part Yes 2 3 No No No No 138
11 51 M Ascending part Yes 2 3 No Obstructive
symptoms
at day 30
No Gastrojejunostomy 165
12 66 M Horizontal part Yes 2 3 No Tissue/tumor
ingrowth
at day 54
No Stent
placement
111
13 66 F Horizontal part Yes 2 4 No No No No 13
14 64 M Horizontal part Yes 1 4 No No No No 26
15 71 M Horizontal part No 1 3 No No No No 21
16 66 F Horizontal part Yes 1 2 No No Yes No 18
Table 2 Main outcomes of duodenum stent placement using a
colonoscope in 16 patients with an obstruction in the distal duodenum
or proximal jejunum
Patients (n = 16)
Technical success (%) 15 (93)
Clinical success (%) 15 (93)
Complications (%) 0 (0)
Recurrent obstruction (%) 7 (44)
Persistent obstruction (%) 1 (6)
Reinterventions (%) 8 (50)*
Median survival (days [SD]) 153 ± 27
* One patient had tissue/tumor ingrowth at day 92 and 242, for which
two stents were placed
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Persistence of obstructive symptoms occurred in one
patient with motility problems. This patient refused addi-
tional treatment and died 18 days after stent placement
from progressive tumor growth.
Reinterventions were only performed for recurrent
obstructive symptoms and included stent placement
(n = 5), gastrojejunostomy (n = 2), and endoscopic
cleansing of the stent (n = 1). Subsequent gastrojejunos-
tomy was performed in two patients with tumor overgrowth
because a second stent could not be placed.
Survival
The 30-day mortality rate was 25% (4/16). Median survival
was 153 days, with four patients still being alive at the end
of our follow-up period (January 1, 2007).
Discussion
The results of this study show that distal duodenal/proxi-
mal jejunal stent placement using a colonoscope is safe and
effective. It was demonstrated that a colonoscope was a
good alternative for a gastroscope in this situation.
In the first nine patients, stent placement was initially
performed with a gastroscope. However, stent placement
failed because of looping of the gastroscope in the stomach
resulting in inability of the endoscope to reach the malig-
nant stricture. For that reason, the gastroscope was changed
for a colonoscope.
In our experience, when a therapeutic gastroscope is used
for stent placement in the distal part of the duodenum or
proximal jejunum, three potential problems may occur.
First, the length of the gastroscope may be insufficient
because of looping in the stomach. Looping is more likely
to occur if the stomach and proximal duodenum are dilated
particularly if the stricture in the duodenum/jejunum has
existed for a prolonged period of time. Second, when
looping occurs, the resulting friction between the stent and
the working channel of the endoscope may prevent the stent
from being advanced out of the endoscope. Third, even
when the stent can be advanced close to an often angulated
stricture, the ability to maintain the gastroscope in a sta-
tionary position in the duodenum is reduced. The resistance
offered by an angulated stricture may result in a retrograde
force pushing the gastroscope back into the stomach, even if
a super-stiff guidewire is advanced through the endoscope.
The colonoscope is obviously longer, provides more stiff-
ness in these cases, and avoids looping in the stomach,
resulting in a stable position close to a stricture distal in the
duodenum and proximal jejunum. In addition, Ross et al.
reported the use of double balloon enteroscopy in combi-
nation with a colonoscope. The technical advantages of this
technique may allow endoscopic stent placement in patients
with a single point of obstruction that is beyond the reach of
conventional endoscopes and existing stent delivery sys-
tems [12]. In our opinion, a newly designed endoscope with
specifications for duodenal stent placement should provide
the following features: (1) a large working channel, which
makes stent placement over the guidewire possible, (2)
adequate stiffness of the endoscope without increasing the
diameter, and (3) sufficient length of the endoscope to reach
distal strictures.
To the best of our knowledge, stent placement for
obstructions in the distal duodenum or proximal jejunum
using a colonoscope has not previously been reported,
although Baron et al. already mentioned the usefulness of
this technique [13]. We compared our results with those
summarized in a recent systematic review summarizing
stent placement for malignant strictures in the distal
stomach or proximal duodenum [14]. Results on food
intake, technical success, complications, and persistent
symptoms were not different. However, mean survival after
stent placement was longer in our study population
(184 versus 85 days). This difference may result from
Fig. 1 Distal duodenum stent placement using a colonoscope. (A)
Introduction of the guidewire and advancing the stent introduction
system over the wire 15 9 15 mm (300 9 300 DPI). (B) Partly
deployed stent at the duodenojejunal flexure (Treitz ligament)
15 9 15 mm (300 9 300 DPI)
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differences in clinical condition. Unfortunately, this was
not clearly stated in the medical records and is therefore
unknown. In addition, recurrent obstructive symptoms
appeared to have occurred more frequently in our patient
population (44% versus 22%), most often due to tissue/
tumor ingrowth. This can probably be explained by the fact
that Dormann et al. included results of both uncovered and
covered stents [14]. Remarkably, 13% (80/606) patients in
this review were treated with a covered esophageal stent
placed in the distal stomach/proximal jejunum. A clear
drawback of uncovered stents in the duodenum is the
occurrence of hyperplastic tissue or tumor growth through
the mesh of the stent [15–17]. In the present study, we only
used uncovered stents, whereas a second uncovered stent
for tissue or tumor ingrowth was performed for six
occluded stents in five patients. The use of covered stents
in the duodenum may overcome this problem of tissue/
tumor ingrowth. The evidence for the safe use of covered
stents in the duodenum is however conflicting in that, on
the one hand, this design may prevent tissue or tumor
ingrowth, but, on the other hand, covered stents are more
likely to migrate than uncovered stents [6, 18]. In addition,
the longer survival in our patient series compared to that in
the review by Dorman et al. may also have resulted in a
higher incidence of recurrent obstructive symptoms. In this
regard, it is important to emphasize that patients with a
good prognosis could potentially gain more benefit from a
laparoscopic gastrojejunostomy as this palliative treatment
has been suggested to be associated with a lower incidence
of recurrent obstructive symptoms compared to stent
placement [19]. If one has to decide on the most optimal
treatment option, it could well be that patients with a poor
clinical condition may gain more benefit from stent
placement, whereas gastrojejunostomy should be reserved
for those with an expected longer survival. Nevertheless, a
large randomized trial has not been performed yet.
Finally, stent placement in the distal duodenum has the
advantage that malignant biliary obstruction occurring after
duodenal stent placement is not precluding the possibility
to perform biliary drainage by endoscopic retrograde
cholangiopancreatography (ERCP) at a later time point.
Biliary obstruction occurs in 2–8 % of patients after stent
placement in the proximal duodenum [1, 2, 20, 21]. It is
often difficult or even impossible to cannulate the papilla
through the mesh of an uncovered stent. Therefore, in
many centers, prior to stent placement in the proximal
duodenum, a stent is placed in the common bile duct [22].
Our results indicate that duodenal stent placement can
effectively and safely be performed using a colonoscope in
patients with an obstruction at the level of the distal duo-
denum or proximal jejunum. A colonoscope has the
advantage that it is long enough and offers good endo-
scopic stiffness, which avoids looping in the stomach.
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